MX2007011665A - Terapeutico para influenza. - Google Patents
Terapeutico para influenza.Info
- Publication number
- MX2007011665A MX2007011665A MX2007011665A MX2007011665A MX2007011665A MX 2007011665 A MX2007011665 A MX 2007011665A MX 2007011665 A MX2007011665 A MX 2007011665A MX 2007011665 A MX2007011665 A MX 2007011665A MX 2007011665 A MX2007011665 A MX 2007011665A
- Authority
- MX
- Mexico
- Prior art keywords
- rnai
- influenza
- inducing
- influenza virus
- provides
- Prior art date
Links
- 206010022000 influenza Diseases 0.000 title abstract 4
- 230000001225 therapeutic effect Effects 0.000 title 1
- 108091030071 RNAI Proteins 0.000 abstract 6
- 230000009368 gene silencing by RNA Effects 0.000 abstract 6
- 230000001939 inductive effect Effects 0.000 abstract 5
- 239000003795 chemical substances by application Substances 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 3
- 241000712461 unidentified influenza virus Species 0.000 abstract 3
- 241000271566 Aves Species 0.000 abstract 1
- 241001500351 Influenzavirus A Species 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 108091027967 Small hairpin RNA Proteins 0.000 abstract 1
- 108020004459 Small interfering RNA Proteins 0.000 abstract 1
- 230000004071 biological effect Effects 0.000 abstract 1
- 230000000295 complement effect Effects 0.000 abstract 1
- 229940124447 delivery agent Drugs 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 210000004072 lung Anatomy 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 210000000056 organ Anatomy 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 230000009261 transgenic effect Effects 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US66458005P | 2005-03-22 | 2005-03-22 | |
| US11/102,097 US20060160759A1 (en) | 2002-09-28 | 2005-04-08 | Influenza therapeutic |
| PCT/US2006/010491 WO2006102461A2 (en) | 2005-03-22 | 2006-03-22 | Influenza therapeutic |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2007011665A true MX2007011665A (es) | 2007-11-14 |
Family
ID=39406020
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2007011665A MX2007011665A (es) | 2005-03-22 | 2006-03-22 | Terapeutico para influenza. |
Country Status (5)
| Country | Link |
|---|---|
| JP (1) | JP2008533990A (enExample) |
| CN (1) | CN101180395A (enExample) |
| IL (1) | IL186057A0 (enExample) |
| MX (1) | MX2007011665A (enExample) |
| NO (1) | NO20074929L (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103966213A (zh) * | 2013-02-06 | 2014-08-06 | 霍晋 | A型流感病毒M基因有干扰作用的siRNA序列的设计和干扰作用的鉴定 |
| CN103966214A (zh) * | 2013-02-06 | 2014-08-06 | 霍晋 | A型流感病毒PB基因有干扰作用的siRNA序列的设计及应用 |
| CN103966212A (zh) * | 2013-02-06 | 2014-08-06 | 霍晋 | A型流感病毒NP基因有干扰作用的siRNA序列的设计及应用 |
| EP3825406A1 (en) * | 2013-06-17 | 2021-05-26 | The Broad Institute Inc. | Delivery and use of the crispr-cas systems, vectors and compositions for hepatic targeting and therapy |
| CN112410275A (zh) * | 2014-01-23 | 2021-02-26 | 科罗拉多州立大学研究基金会 | 流感的大肠杆菌介导的siRNA沉默 |
| CN106381296A (zh) * | 2015-11-19 | 2017-02-08 | 中国农业科学院哈尔滨兽医研究所 | 表达多基因抗流感转基因动物的构建方法 |
| CN106947763B (zh) * | 2017-03-20 | 2019-11-12 | 中国医学科学院医药生物技术研究所 | 可雾化吸入的抗流感病毒感染的siRNA及其应用 |
| US11931416B2 (en) | 2019-02-01 | 2024-03-19 | The Board Of Trustees Of The Leland Stanford Junior University | Immolative cell-penetrating complexes for nucleic acid delivery to the lung |
| US20220249678A1 (en) * | 2019-07-10 | 2022-08-11 | The University Of Hong Kong | PEGylated synthetic KL4 peptide, Compositions and Methods Thereof |
-
2006
- 2006-03-22 JP JP2008503156A patent/JP2008533990A/ja active Pending
- 2006-03-22 CN CNA2006800177344A patent/CN101180395A/zh active Pending
- 2006-03-22 MX MX2007011665A patent/MX2007011665A/es not_active Application Discontinuation
-
2007
- 2007-09-19 IL IL186057A patent/IL186057A0/en unknown
- 2007-09-28 NO NO20074929A patent/NO20074929L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2008533990A (ja) | 2008-08-28 |
| CN101180395A (zh) | 2008-05-14 |
| IL186057A0 (en) | 2008-01-20 |
| NO20074929L (no) | 2007-12-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2006102461A3 (en) | Influenza therapeutic | |
| Tu et al. | Ischemic postconditioning-mediated miRNA-21 protects against cardiac ischemia/reperfusion injury via PTEN/Akt pathway | |
| NO20074929L (no) | Influensa terapeutisk middel | |
| Zhang et al. | Induction of the cellular miR-29c by influenza virus inhibits the innate immune response through protection of A20 mRNA | |
| MX2023010958A (es) | Agentes de arn modificados con efecto reducido fuera de la diana. | |
| Selvamani et al. | Chikungunya virus exploits miR-146a to regulate NF-κB pathway in human synovial fibroblasts | |
| MX385869B (es) | Agentes de iarn modificados. | |
| MX2024005653A (es) | Agentes de acido ribonucleico (arn) de cadena doble modificados. | |
| JP2010505897A (ja) | インフルエンザターゲット | |
| JP2024500036A (ja) | 抱合体 | |
| JP2019508045A (ja) | がんを処置するための組み合わせベクターおよび方法 | |
| Ouyang et al. | gga-miR-2127 downregulates the translation of chicken p53 and attenuates chp53-mediated innate immune response against IBDV infection | |
| WO2019217397A3 (en) | Compositions and methods for improving strand biased | |
| BR112019009953A2 (pt) | substâncias direcionadas a vários órgãos ou tecidos selecionados | |
| US20110184045A1 (en) | Silencng and rig-i activation by dual function oligonucleotides | |
| US20200345756A1 (en) | Compositions and methods for treating age-related macular degeneration and geographic atrophy | |
| Stoppani et al. | Expression of a single siRNA against a conserved region of NP gene strongly inhibits in vitro replication of different Influenza A virus strains of avian and swine origin | |
| KR101638156B1 (ko) | C형 간염 바이러스 감염 질환의 예방 또는 치료용 약학 조성물 | |
| RU2013121802A (ru) | Профилактический или терапевтический агент для лечения фиброза | |
| RU2016131028A (ru) | Композиции, содержащие асимметричную интерферирующую рнк, которые подвергают сайленсингу k-ras, и способы их применения | |
| Stewart et al. | Immunostimulatory motifs enhance antiviral siRNAs targeting highly pathogenic avian influenza H5N1 | |
| Talari et al. | MicroRNA-712 restrains macrophage pro-inflammatory responses by targeting LRRK2 leading to restoration of insulin stimulated glucose uptake by myoblasts | |
| Chen et al. | ADAR1 is targeted by miR-143 to regulate IL-1β-induced endothelial activation through the NFκB pathway | |
| Liu et al. | ASF1a enhances antiviral immune response by associating with CBP to mediate acetylation of H3K56 at the Ifnb promoter | |
| JP4054844B2 (ja) | 副作用のないＲＮＡｉ医薬 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |